Bonesupport Holding AB
STO:BONEX

Watchlist Manager
Bonesupport Holding AB Logo
Bonesupport Holding AB
STO:BONEX
Watchlist
Price: 360 SEK 4.05% Market Closed
Market Cap: 23.7B SEK
Have any thoughts about
Bonesupport Holding AB?
Write Note

Relative Value

The Relative Value of one BONEX stock under the Base Case scenario is 243.27 SEK. Compared to the current market price of 360 SEK, Bonesupport Holding AB is Overvalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BONEX Relative Value
Base Case
243.27 SEK
Overvaluation 32%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
0
vs Industry
28
Median 3Y
18.7
Median 5Y
18.7
Industry
7.7
Forward
25.3
vs History
0
vs Industry
3
Median 3Y
-34.6
Median 5Y
-33.7
Industry
22.7
Forward
190
vs History
0
vs Industry
0
Median 3Y
-96.8
Median 5Y
-48.5
Industry
21.6
vs History
vs Industry
Median 3Y
-93.1
Median 5Y
-45.6
Industry
25.2
vs History
0
vs Industry
2
Median 3Y
21.4
Median 5Y
16
Industry
2.5
vs History
0
vs Industry
24
Median 3Y
18.4
Median 5Y
18.4
Industry
7.7
Forward
25.2
vs History
0
vs Industry
20
Median 3Y
20.2
Median 5Y
20.2
Industry
9
vs History
14
vs Industry
0
Median 3Y
-38.6
Median 5Y
-31.8
Industry
4.2
Forward
153
vs History
14
vs Industry
0
Median 3Y
-36.7
Median 5Y
-30.6
Industry
4.1
Forward
149
vs History
0
vs Industry
0
Median 3Y
-93.4
Median 5Y
-45
Industry
5.7
vs History
vs Industry
Median 3Y
-123.7
Median 5Y
-55.1
Industry
3.6
vs History
20
vs Industry
9
Median 3Y
31.1
Median 5Y
31.1
Industry
4.6

Multiples Across Competitors

BONEX Competitors Multiples
Bonesupport Holding AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Bonesupport Holding AB
STO:BONEX
23.6B SEK 29.5 265.1 224.1 249.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 5.9 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.5 -76.2
P/E Multiple
Earnings Growth
SE
Bonesupport Holding AB
STO:BONEX
Average P/E: 217.8
265.1
116%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
SE
Bonesupport Holding AB
STO:BONEX
Average EV/EBITDA: 46.7
224.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
SE
Bonesupport Holding AB
STO:BONEX
Average EV/EBIT: 54.9
249.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top